# RIMS3

## Overview
RIMS3, or Regulating Synaptic Membrane Exocytosis 3, is a gene that encodes a protein integral to the presynaptic machinery involved in synaptic vesicle fusion and neurotransmitter release. The protein encoded by RIMS3 is a member of the RIM protein family, which plays a crucial role in calcium-triggered exocytosis at the synaptic membrane, thereby facilitating synaptic transmission and communication between neurons (Kumar2009A). Predominantly expressed in the brain, particularly in rostral regions, the RIMS3 protein interacts with several other proteins, including a-liprins, SNAP-25, and voltage-gated calcium channels, through its C2B domain, which is essential for normal brain development and synapse function (Kumar2009A). Disruptions in the function of RIMS3 have been implicated in neurodevelopmental disorders, such as autism spectrum disorders, highlighting its significance in maintaining normal cognitive functions (Kumar2009A).

## Function
The RIMS3 gene encodes a protein that is integral to the presynaptic machinery involved in synaptic vesicle fusion and neurotransmitter release. In healthy human cells, RIMS3 plays a crucial role in facilitating calcium-triggered exocytosis, acting as a regulator of exocytosis at the synaptic membrane (Kumar2009A). This process is essential for the proper functioning of synaptic transmission, which is vital for communication between neurons. RIMS3 is expressed predominantly in the brain, particularly in rostral regions, and is not found in the spinal cord, hindbrain, or midbrain (Kumar2009A).

The protein interacts with several other proteins, including a-liprins, SNAP-25, and voltage-gated calcium channels, through its C2B domain. These interactions are important for the regulation of presynaptic proteins and are critical for normal brain development and synapse function (Kumar2009A). The role of RIMS3 in synaptic function and neuronal cell adhesion underscores its importance in maintaining normal brain activity and development. Disruptions in these processes can have significant implications for cognitive functions such as learning and memory, highlighting the gene's potential involvement in neurological disorders like autism (Kumar2009A).

## Clinical Significance
Mutations and alterations in the expression of the RIMS3 gene have been associated with various neurodevelopmental disorders, particularly autism spectrum disorders (ASD). The gene is implicated in the connectivity of autism-related copy number variations (CNVs), with studies highlighting its role in linking genetic risk factors at the protein level (Corominas2014Protein). RIMS3 has been identified as one of the genes disrupted by balanced chromosomal abnormalities in individuals with autism and other neurodevelopmental disorders, suggesting shared genetic risk factors across these conditions (Talkowski2012Sequencing). 

Despite its inclusion in datasets of autism-related genes, RIMS3's clinical significance in terms of variant interactions may be less pronounced compared to other genes, as indicated by its lower total gene score in some studies (Larsen2016A). Nonetheless, the gene's involvement in novel protein-protein interactions and its presence in de novo CNVs associated with autism underscore its potential role in the molecular networks shared among different ASD patients (Corominas2014Protein). These findings suggest that RIMS3 could be significant in understanding the genetic architecture of autism and related disorders.

## Interactions
RIMS3, a protein involved in synaptic vesicle exocytosis, participates in several interactions crucial for synaptic function. It is part of the RIM protein family, which plays a significant role in synaptic vesicle fusion and neurotransmitter release. RIMS3 directly interacts with the protein tyrosine phosphatase PPFIA3, a member of the liprin-a gene family, which is involved in synaptic organization and function (Kumar2009A). Additionally, RIMS3 is indirectly associated with other autism candidate genes through its interaction with FMR1, a gene known for its role in fragile X syndrome (Kumar2009A).

The protein also interacts with components of the presynaptic active zone, such as SNAP-25 and voltage-gated calcium channels, through its C2B domain. This domain is crucial for its role in synaptic transmission, although the critical residues for some interactions are located downstream of the p.E177 variant (Kumar2009A). RIMS3's interactions are essential for synaptic plasticity and efficient synaptic transmission, highlighting its potential involvement in neurodevelopmental disorders like autism (Kumar2009A). These interactions suggest that RIMS3 may contribute to the pathophysiology of autism through synaptic dysfunction.


## References


[1. (Kumar2009A) R. A. Kumar, J. Sudi, T. D. Babatz, C. W. Brune, D. Oswald, M. Yen, N. J. Nowak, E. H. Cook, S. L. Christian, and W. B. Dobyns. A de novo 1p34.2 microdeletion identifies the synaptic vesicle gene rims3 as a novel candidate for autism. Journal of Medical Genetics, 47(2):81–90, June 2009. URL: http://dx.doi.org/10.1136/jmg.2008.065821, doi:10.1136/jmg.2008.065821. This article has 43 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1136/jmg.2008.065821)

[2. (Larsen2016A) Eric Larsen, Idan Menashe, Mark N. Ziats, Wayne Pereanu, Alan Packer, and Sharmila Banerjee-Basu. A systematic variant annotation approach for ranking genes associated with autism spectrum disorders. Molecular Autism, October 2016. URL: http://dx.doi.org/10.1186/s13229-016-0103-y, doi:10.1186/s13229-016-0103-y. This article has 46 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13229-016-0103-y)

[3. (Corominas2014Protein) Roser Corominas, Xinping Yang, Guan Ning Lin, Shuli Kang, Yun Shen, Lila Ghamsari, Martin Broly, Maria Rodriguez, Stanley Tam, Shelly A. Wanamaker, Changyu Fan, Song Yi, Murat Tasan, Irma Lemmens, Xingyan Kuang, Nan Zhao, Dheeraj Malhotra, Jacob J. Michaelson, Vladimir Vacic, Michael A. Calderwood, Frederick P. Roth, Jan Tavernier, Steve Horvath, Kourosh Salehi-Ashtiani, Dmitry Korkin, Jonathan Sebat, David E. Hill, Tong Hao, Marc Vidal, and Lilia M. Iakoucheva. Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism. Nature Communications, April 2014. URL: http://dx.doi.org/10.1038/ncomms4650, doi:10.1038/ncomms4650. This article has 128 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms4650)

[4. (Talkowski2012Sequencing) Michael E. Talkowski, Jill A. Rosenfeld, Ian Blumenthal, Vamsee Pillalamarri, Colby Chiang, Adrian Heilbut, Carl Ernst, Carrie Hanscom, Elizabeth Rossin, Amelia M. Lindgren, Shahrin Pereira, Douglas Ruderfer, Andrew Kirby, Stephan Ripke, David J. Harris, Ji-Hyun Lee, Kyungsoo Ha, Hyung-Goo Kim, Benjamin D. Solomon, Andrea L. Gropman, Diane Lucente, Katherine Sims, Toshiro K. Ohsumi, Mark L. Borowsky, Stephanie Loranger, Bradley Quade, Kasper Lage, Judith Miles, Bai-Lin Wu, Yiping Shen, Benjamin Neale, Lisa G. Shaffer, Mark J. Daly, Cynthia C. Morton, and James F. Gusella. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell, 149(3):525–537, April 2012. URL: http://dx.doi.org/10.1016/j.cell.2012.03.028, doi:10.1016/j.cell.2012.03.028. This article has 493 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cell.2012.03.028)